Indian Pharma Companies: 10 Businesses That Are Now The Best

Indian Pharma Companies: 10 Businesses That Are Now The Best

Presently, India is the biggest provider of generic medicines, grabbing a market share of 20 percent to global supply in respect to volume and caters digitally 60 percent of the vaccine needs across the globe. Indian pharma companies also supply 80 percent of antiretroviral medications in the international markets. 

The prevailing pandemic has increased in healthcare centers, because of which new and old pharmaceutical companies in this country have catered to the huge requirement of the society. 

Top 10 Indian Pharma Companies

The international pharmaceutical market is expected to surpass USD 1.5 trillion by 2023. India received an important position in the global pharma space. India offers over 50% of the global requirement for varied vaccines and 40% of the demand for the generic items in the US. 

The spending on pharmaceuticals in India is anticipated to expand at 8-11% CAGR during 2019-23 to attain 28-32 Billion US dollars. The top 10 Indian pharma companies in the year 2022 are:

1. Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Ltd is a multinational pharmaceutical company of India that is headquartered in Mumbai, Maharashtra that sells and manufactures pharmaceutical formulations and APIs (active pharmaceutical ingredients) primarily in India and the US.

This company has a 24.09 percent Stock Weightage in Nifty Pharma. The entity has total sales of Rs 29066 Cr. This is among the biggest Indian pharma companies by revenue and also market capital.

  • Revenue: ₹ 34,357 Cr
  • ROE: 9.19 %
  • Sales Growth (3Yrs): 0.67 %
  • Promoter holding: 54.56 %
  • Debt to equity: 0.25
  • Price to book value: 2.28

2. Aurobindo Pharma Ltd

Established in 1986 by Mr. K. Nityananda Reddy, Mr. P. V. Ramprasad Reddy,  and a small group of highly committed professionals, this company was born of a vision. The entity began functioning in 1988-89 with a single unit manufacturing SSP (Semi-Synthetic Penicillin) at Pondicherry. The entity has total sales of Rs 19564 Cr. 

Aurobindo Pharma changed into a public company in 1992 and listed its shares on the stock exchanges in 1995. Along with that to be the market leader in Semi-Synthetic Penicillins, it has a mark in key therapeutic segments like cardiovascular, antiretrovirals, neurosciences, anti-diabetics, antibiotics, and gastroenterology, among others.

  • Revenue: ₹ 28,404 Cr
  • ROE: 19.01 %
  • Sales Growth (3Yrs): 12.41 %
  • Promoter holding: 51.87 %
  • Debt to equity: 0.37
  • Price to book value: 1.82

3. Lupin

Lupin is a global pharma company that provides a broad range of items like biotechnology products, branded and generic formulations, active pharmaceutical ingredients (APIs), and specialty products. The entity has total sales of Rs 16718 Crs. The world-class manufacturing facilities of Lupin are spread across Japan, USA, Mexico, India, and Brazil.

This company is a significant player in the therapy space of Cardiovascular, Diabetology, Gynecology, Asthma, Pediatric, Gastro-Intestinal (GI), Anti-Infective (AI), Central Nervous systems (CNS),  and Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).

  • Revenue: ₹ 15,300 Cr
  • ROE: 5.38 %
  • Sales Growth (3Yrs): 5.46 %
  • Promoter holding: 46.93 %
  • Debt to equity: 0.64
  • Price to book value: 2.17

4. Cipla

Cipla is among the best Indian pharma companies across the globe that are dedicated to branded, high-quality, and generic medicines. The entity is trusted by patients and healthcare professionals across geographies.

The entity has a total sales of Rs 16362 Cr. This company is fourth-largest in this list of the top 10 best pharma companies in India. 

  • Revenue: ₹ 19,425 Cr
  • ROE: 9.62 %
  • Sales Growth (3Yrs): 5.87 %
  • Promoter holding: 36.65 %
  • Debt to equity: 0.23
  • Price to book value: 2.20

5. Dr. Reddy’s Laboratories Ltd

Dr. Reddy’s Laboratories is a multinational pharmaceutical company of India that is based in Hyderabad, Telangana, India. Dr. Reddy’s Laboratories Ltd has a 17.00 percent Stock Weightage in the Nifty Pharma Index. The entity has total sales of Rs 14500 Crs. The business comes among the top 100 pharmaceutical companies in India as well. 

  • Revenue: ₹ 19,386 Cr
  • ROE: 13.61 %
  • Sales Growth (3Yrs): -0.26 %
  • Promoter holding: 26.76 %
  • Debt to equity: 0.17
  • Price to book value: 3.30

6. Cadila Healthcare Ltd

Zydus Cadila has its headquarters in Ahmedabad, India, and ranks 6th in the Indian pharmaceutical sector. The group has research facilities and manufacturing sites spread across five states of Maharashtra, Goa, Himachal Pradesh, Gujarat, and Sikkim in India and in Brazil, and the United States.

The innovation program of this company is spearheaded by 1300 researchers throughout 19 sites, operating on differentiated medicines for the future. From NCEs to vaccines, biosimilars, and also niche technologies, the group is finding out varied concepts and ideas, innovating constantly.

  • Revenue:  ₹ 15, 139 Cr.
  • ROE: 18.66 %
  • Sales Growth (3Yrs): 11.78 %
  • Promoter holding: 74.88 %
  • Debt to equity: 0.69
  • Price to book value: 2.55

7. Glenmark Pharmaceuticals Ltd

This is among the top 10 pharmaceutical companies in India 2022. Glenmark Pharmaceuticals is engaged in the development of NCEs (new chemical entities) and also new biological entities (NBEs).

The entity has several molecules in varying stages of clinical and pre-clinical development and is basically aimed at the areas of Respiratory, Oncology, and Dermatology.

  • Revenue: ₹ 11,038 Cr.
  • ROE: 15.20 %
  • Sales Growth (3Yrs): 9.27 %
  • Promoter holding: 46.59 %
  • Debt to equity: 0.60
  • Price to book value: 1.27

8. Torrent Pharmaceuticals Ltd

Torrent Pharma, which is the flagship company of Torrent Group is among the best Indian pharma companies presently. The company was a pioneer in starting the idea of niche marketing in India and presently it is ranked amongst the leaders in the therapeutic segment of the central nervous system (CNS), cardiovascular (CV), gastrointestinal (GI), and women’s healthcare (WHC).

  • Revenue: ₹ 8,061 Cr.
  • ROE: 12.75 %
  • Sales Growth (3Yrs): 4.69 %
  • Promoter holding: 71.25 %
  • Debt to equity: 0.85
  • Price to book value: 7.00

9. Alkem Laboratories Ltd

Founded in 1973, high-quality branded generics, active pharmaceutical ingredients, generic drugs, and nutraceuticals, which the entity markets in India and more than 50 nations internationally.

With a comprehensive portfolio of more than 750 brands covering all the important therapeutic segments and a broad pan-India sales and distribution channel, this company is ranked amongst the top Indian pharmaceutical companies in respect to domestic sales for the last 15 years.

  • Revenue: ₹ 9,098 Cr.
  • ROE: 14.84 %
  • Sales Growth (3Yrs): 14.47 %
  • Promoter holding: 66.04 %
  • Debt to equity: 0.24
  • Price to book value: 5.22
  • The company have also been

10. Divi’s Laboratories Ltd

Divis Laboratories is occupied in the manufacture of APIs (Active Pharmaceutical Ingredients), Intermediates, and Nutraceutical items with predominance in exports. The business has a total net sales of Rs 4880 Crs. Divi’s has been founded for over 29 years in Hyderabad, India with 2 manufacturing units and it is among the top pharma companies in India.

  • Market Cap:  57,919 Cr.
  • ROE: 21.01 %
  • Sales Growth (3Yrs): 9.41 %
  • Promoter holding: 52.00 %
  • Debt to equity: 0.00
  • Price to book value: 8.18

Conclusion

The global pharmaceutical market is anticipated to exceed USD 1.5 Trillion by 2023. With the prevailing pandemic, this industry has witnessed a great shift and will continue to in the upcoming years. Various big pharma companies have come to the forefront with their manufacturing and so in the above article, we have discussed the top 10 Indian pharma companies who are presently leading the Indian pharmaceutical market.

924 Views
Avatar photo

Yaseer Rashid

Yaseer Rashid got a degree in Journalism and worked as a freelancer. Later he joined News Magnify as a Business and stock writer.

Leave a Reply

Your email address will not be published. Required fields are marked *